Incidence of plantar fascia ruptures following corticosteroid injection.
Plantar fasciitis is commonly treated with corticosteroid injections to decrease pain and inflammation. Therapeutic benefits often vary in terms of efficacy and duration. Rupture of the plantar fascia has been reported as a possible complication following corticosteroid injection. A retrospective chart review of 120 patients who received corticosteroid injection for plantar fasciitis was performed at the authors' institution to determine the incidence of plantar fascia rupture. The plantar fascia rupture was diagnosed clinically and confirmed with magnetic resonance imaging. Various factors were analyzed, including the number of injections, interval between injections, body mass index (BMI), and activity level. Four patients (2.4%) consequently experienced plantar fascia rupture following an average of 2.67 injections. The average BMI of these patients was 38.6 kg/m². The authors conclude that corticosteroid injection therapy appears to be a safe and effective form of nonoperative treatment with minimal complications and a relatively low incident of plantar fascia rupture.
Kim
Chul
C
Department of Foot & Ankle Surgery, The Western Pennsylvania Hospital, Pittsburgh, Pennsylvania 15224, USA.
Cashdollar
Michael R
MR
Mendicino
Robert W
RW
Catanzariti
Alan R
AR
Fuge
LaDonna
L
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015992:Body Mass Index; D003907:Dexamethasone / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D005205:Fascia / Q000293:injuries* / Q000473:pathology; D036981:Fasciitis, Plantar / Q000188:drug therapy*; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007267:Injections / Q000009:adverse effects*; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012421:Rupture / Q000209:etiology; D014222:Triamcinolone Acetonide / Q000008:administration & dosage / Q000009:adverse effects
D005938:Glucocorticoids; C004180:dexamethasone 21-phosphate; D003907:Dexamethasone; D014222:Triamcinolone Acetonide